Trial Profile

A pivotal bioequivalence clinical study with Sumatriptan Alginate Film

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 27 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sumatriptan (Primary) ; Sumatriptan
Indications Migraine
Focus Pharmacodynamics; Pharmacokinetics; Registrational
Sponsors Klaria AB

Most Recent Events

27 Sep 2021 New trial record
05 May 2021 According to a Klaria AB media release, the last subject was dosed in March 2021
12 Nov 2020 According to a Klaria AB media release, company completed manufacturing of the clinical material of Sumatriptan Alginate Film. Company has received approval from the UK Research Ethics Committee Klaria has received approval of the Clinical Trial Application from the MHRA (the UK Competent Authority).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com